( NASDAQ-NMS:JAZZ )

News from jazz pharmaceuticals plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 18, 2016, 16:05 ET Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...


May 10, 2016, 16:05 ET Jazz Pharmaceuticals Announces First Quarter 2016 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2016 and updated financial guidance for...


Apr 26, 2016, 16:05 ET Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 first quarter financial results on Tuesday, May 10, 2016,...


Mar 30, 2016, 14:41 ET Jazz Pharmaceuticals Announces Webcast for Defitelio® (defibrotide sodium) Investor Update

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Thursday, March 31, 2016 at 4:30 p.m. EDT/9:30 p.m....


Mar 30, 2016, 14:32 ET Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT)

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Food and Drug Administration (FDA) granted...


Mar 02, 2016, 16:05 ET Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...


Feb 23, 2016, 16:05 ET Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter of 2015 and provided...


Feb 18, 2016, 09:05 ET Jazz Pharmaceuticals To Present Data From Ongoing Evaluations Of Defibrotide At The 2016 BMT Tandem Meeting

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present three Jazz-sponsored oral abstracts related to the...


Feb 09, 2016, 16:05 ET Jazz Pharmaceuticals to Report 2015 Fourth Quarter and Full Year Financial Results on February 23, 2016

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 fourth quarter and full year financial results on...


Feb 01, 2016, 09:05 ET Results from Phase 3 Trial of Defibrotide for the Treatment of Severe Veno-Occlusive Disease and Multi-Organ Failure Published Online in BLOOD

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that data from the phase 3 pivotal study of defibrotide were published online in...


Jan 04, 2016, 16:05 ET Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 11

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 34th Annual J.P....


Nov 04, 2015, 16:05 ET Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at three upcoming investor...


Oct 26, 2015, 16:05 ET Jazz Pharmaceuticals to Report 2015 Third Quarter Financial Results on November 9, 2015

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 third quarter financial results on Monday, November 9, 2015,...


Sep 30, 2015, 08:30 ET Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted for...


Aug 05, 2015, 16:05 ET Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2015 and reaffirmed financial guidance for...


Jul 22, 2015, 16:05 ET Jazz Pharmaceuticals to Report 2015 Second Quarter Financial Results on August 5, 2015

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 second quarter financial results on Wednesday, August 5,...


Jul 01, 2015, 16:05 ET Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the Cantor Fitzgerald...


Jun 08, 2015, 09:05 ET Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Clinical Development Program Evaluating JZP-110 as a Potential Treatment of Excessive Daytime Sleepiness (EDS) Associated with Narcolepsy or with Obstructive Sleep Apnea (OSA)

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the first patients have been enrolled in a Phase 3 clinical development...


Jun 04, 2015, 09:05 ET Jazz Pharmaceuticals to Present Abstracts from Ongoing Evaluations of Xyrem® (sodium oxybate) at SLEEP 2015

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will present abstracts related to the ongoing clinical evaluation of Xyrem® (sodium oxybate)...


May 15, 2015, 16:05 ET Jazz Pharmaceuticals Announces Participation in Two Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor...


May 07, 2015, 16:05 ET Jazz Pharmaceuticals Announces First Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter ended March 31, 2015 and reaffirmed...


Apr 23, 2015, 16:05 ET Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2015 first quarter financial results on Thursday, May 7,...


Feb 24, 2015, 16:05 ET Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2014 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter ended December 31, 2014 and...


Feb 23, 2015, 16:05 ET Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor...


Feb 12, 2015, 08:30 ET Jazz Pharmaceuticals to Present Data on Defibrotide, an Investigational Treatment, in Patients with Hepatic Veno-Occlusive Disease (VOD) at BMT Tandem Meetings

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present data on the use of defibrotide, an investigational...